Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Promethazine for Prevention of Postoperative Nausea and Vomiting After TMJ Disc Reduction and Fixation
ChiCTR2600125111Phase 4Not yet recruiting
- Sponsor
- Affiliated Stomatology Hospital of Guangzhou Medical University
- Start
- May 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of promethazine in postoperative nausea and vomiting (PONV) (3 arms), sponsored by Affiliated Stomatology Hospital of Guangzhou Medical University. Primary endpoint: Incidence of postoperative nausea and vomiting. Planned start May 2026; status: not yet recruiting.
02
Drugs
promethazine
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on ChiCTR2600125111.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600125111.